Literature DB >> 7506393

L-type calcium channel activity in human atrial myocytes as influenced by 5-HT.

U Jahnel1, H Nawrath, J Rupp, R Ochi.   

Abstract

5-Hydroxytryptamine (10 mumol/l; 5-HT) exerted a positive inotropic effect associated with an increase in the Ca2+ current (ICa) in the human right atrium. For detailed analysis, L-type Ca2+ channel currents were recorded from cell-attached patches using 100 mmol/l Ba2+ as charge carrier. Ca2+ channel activity was identified, first, by burst-like inwardly directed currents and, second, by the appearance of long channel openings promoted by Bay K 8644 (1 mumol/l) upon repetitive depolarizations from -80 to 0 mV. The unitary conductance of the Ca2+ channel amounted to 25.8 pS. During superfusion with 5-HT, ensemble averaged (mean) current was enhanced by about 60%. The increase in mean current was brought about by an increase in the channel availability, defined as the ratio of sweeps containing Ca2+ channel activity to the total number of depolarizations. The open probability of a single Ca2+ channel within a sweep with channel activity, unitary conductance, mean open and mean shut times of the channel, however, remained unaffected during superfusion with 5-HT (n = 10). The 5-HT-induced increase in macroscopic ICa in the human atrium can therefore be explained by an enhanced availability of Ca2+ channels to open upon depolarization. The observed changes in gating properties of the human Ca2+ channel by 5-HT are very similar to those which are known from isoprenaline-induced cAMP-dependent phosphorylation of the Ca2+ channel protein in other tissues.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7506393     DOI: 10.1007/bf00171339

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  23 in total

1.  Fast and slow gating behaviour of single calcium channels in cardiac cells. Relation to activation and inactivation of calcium-channel current.

Authors:  A Cavalié; D Pelzer; W Trautwein
Journal:  Pflugers Arch       Date:  1986-03       Impact factor: 3.657

2.  Mechanism of adenosine-induced inhibition of calcium current in guinea pig ventricular cells.

Authors:  M Kato; H Yamaguchi; R Ochi
Journal:  Circ Res       Date:  1990-11       Impact factor: 17.367

Review 3.  Regulation of cardiac L-type calcium current by phosphorylation and G proteins.

Authors:  W Trautwein; J Hescheler
Journal:  Annu Rev Physiol       Date:  1990       Impact factor: 19.318

4.  Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists.

Authors:  P Hess; J B Lansman; R W Tsien
Journal:  Nature       Date:  1984 Oct 11-17       Impact factor: 49.962

5.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

6.  Modulation of slow gating process of calcium channels by isoprenaline in guinea-pig ventricular cells.

Authors:  R Ochi; Y Kawashima
Journal:  J Physiol       Date:  1990-05       Impact factor: 5.182

7.  Characteristics of calcium-current in isolated human ventricular myocytes from patients with terminal heart failure.

Authors:  D J Beuckelmann; M Näbauer; E Erdmann
Journal:  J Mol Cell Cardiol       Date:  1991-08       Impact factor: 5.000

8.  Serotonin increases calcium current in human atrial myocytes via the newly described 5-hydroxytryptamine4 receptors.

Authors:  H Ouadid; J Seguin; A Dumuis; J Bockaert; J Nargeot
Journal:  Mol Pharmacol       Date:  1992-02       Impact factor: 4.436

9.  Characteristics of the time-dependent slow inward current in adult human atrial single myocytes.

Authors:  D Escande; A Coulombe; J F Faivre; E Coraboeuf
Journal:  J Mol Cell Cardiol       Date:  1986-05       Impact factor: 5.000

10.  Dihydropyridine derivatives prolong the open state of Ca channels in cultured cardiac cells.

Authors:  S Kokubun; H Reuter
Journal:  Proc Natl Acad Sci U S A       Date:  1984-08       Impact factor: 11.205

View more
  8 in total

1.  Cardiovascular effects of cisapride and prucalopride on human 5-HT4 receptors in transgenic mice.

Authors:  Nicolas Keller; Stefan Dhein; Joachim Neumann; Ulrich Gergs
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-06-09       Impact factor: 3.000

2.  Desensitization of the human 5-HT4 receptor in isolated atria of transgenic mice.

Authors:  Ulrich Gergs; Julia Fritsche; Stephanie Fabian; Josepha Christ; Joachim Neumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-07-08       Impact factor: 3.000

3.  Effects of treatment with a 5-HT4 receptor antagonist in heart failure.

Authors:  J A K Birkeland; I Sjaastad; T Brattelid; E Qvigstad; E R Moberg; K A Krobert; R Bjørnerheim; T Skomedal; O M Sejersted; J-B Osnes; F O Levy
Journal:  Br J Pharmacol       Date:  2006-12-11       Impact factor: 8.739

4.  Functional serotonin 5-HT4 receptors in porcine and human ventricular myocardium with increased 5-HT4 mRNA in heart failure.

Authors:  Trond Brattelid; Eirik Qvigstad; James A Lynham; Peter Molenaar; Halfdan Aass; Odd Geiran; Tor Skomedal; Jan-Bjørn Osnes; Finn Olav Levy; Alberto J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-09-07       Impact factor: 3.000

5.  Electrophysiological effects of 5-hydroxytryptamine on isolated human atrial myocytes, and the influence of chronic beta-adrenoceptor blockade.

Authors:  Davide Pau; Antony J Workman; Kathleen A Kane; Andrew C Rankin
Journal:  Br J Pharmacol       Date:  2003-11-17       Impact factor: 8.739

Review 6.  Trazodone and omeprazole interaction causing frequent second-degree Mobitz type 1 atrioventricular (AV) block (Wenckebach phenomenon) and syncope: a case report and literature review.

Authors:  Oluwaseun A Akinseye; Mostafa Alfishawy; Farshid Radparvar; Sanjiv Bakshi
Journal:  Am J Case Rep       Date:  2015-05-27

7.  A xanthine-derivative K(+)-channel opener protects against serotonin-induced cardiomyocyte hypertrophy via the modulation of protein kinases.

Authors:  Hsuan-Fu Kuo; Yan-Jie Lai; Jung-Chou Wu; Kun-Tai Lee; Chih-Sheng Chu; Ing-Jun Chen; Jiunn-Ren Wu; Bin-Nan Wu
Journal:  Int J Biol Sci       Date:  2013-12-17       Impact factor: 6.580

8.  Asenapine modulates nitric oxide release and calcium movements in cardiomyoblasts.

Authors:  Elena Grossini; Carla Gramaglia; Serena Farruggio; Lara Camillo; David Mary; Giovanni Vacca; Patrizia Zeppegno
Journal:  J Pharmacol Pharmacother       Date:  2016 Jan-Mar
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.